Blue Horseshoe Stocks: Earnings and Bottom Plays

Acuity Brands, inc. AYI – Options Idea

After a lackluster Q3 report, AYI took a gut punch yesterday, but began to recover before the day was through, and appears to want to continue to course-correct today.

We are going to radar the AYI 07/19 $125-130 Calls. Even if this holiday shortened week comes to a predictably quiet close and doesn’t provide a ton of activity, we’ll still have plenty of time to get results before the 19th.


comScore, Inc. SCOR 

We’ve found what appears to be a prime bottom-watch candidate in SCOR. The stock is egregiously oversold at the present time, and has managed a couple of positive sessions this week.

The volatility potential on this stock is high. It’s not unreasonable to think that it could return to the $10 level or better over a period of several weeks or perhaps even months. We’ll designate this as a longer-term recovery play.


Extended Watchlist:
TBLT, NAK, ZIOP, FCEL, SNSS, OTLK

Blue Horseshoe Stocks: PIRS Review & More

Pieris Pharmaceuticals Inc. PIRS – Review

Of all the types of plays we search for, bottom watch plays can require the most amount of patience as compared to other quick-strike ideas that we formulate. We highlighted PIRS as such back in mid-February, and over the past quarter, the stock has produced some very favorable results in two distinct runs.

When we initially signaled our interest in this stock, or shortly thereafter, it was trading for as little as 2.83 and over the course of the next two months, it gradually made its way to 4.00 (+41%). After a pullback down near its original level at 2.81 halfway through last month, the stock has begun to run once again. This time it has reached all new highs, with the stock changing hands for as much as 4.68/share on Friday. That second push allowed us to see an overall increase of 67%

We wouldn’t be at all surprised to have to come back to PIRS once again in the near future. In addition to the company’s joint clinical venture with pharma super giant AstraZeneca, the stock itself has recently received analyst upgrades that could just be the beginning of PIRS’s next leg-up.


Xalles Holdings, Inc. XALL

We are also looking at the incredible momentum recently built up by XALL, which has been assisted by the resurgence of Bitcoin here in 2019, which began in January in the mid-$3000 range, and has persisted to the present time to the current highs near $8700.

The company also recently decreased its public float by around 50%, making it that much easier for the stock to move. We’ll be interested to continue to monitor its progress, especially if the latest Bitcoin boom continues to persist as it has in recent months.


Extended Watchlist:
DRRX, CBLK, BLNK, CTRV, MOSY, SNSS, NVCN, ATVI, LAHO(>>News Alert)

Blue Horseshoe Stocks: Options Review & More

Options Review

Bed Bath & Beyond, Inc. BBBY – Yesterday morning’s premarket report contained an options idea for Bed Bath & Beyond following the company’s quarterly earnings report, the BBBY Weekly $13 & $13.50 Calls, and those plays both turned in fantastic intraday performances.

Regardless of which strike point was chosen, traders could have secured multi-bag profits on the day. The $13 Calls traded up from a low of .30 to a high of 1.30, for an increase of 333%, while the $13.50′s also crushed it with a huge 431% rip from .16-.85!
_______

Constellation Brands Inc. STZ -Just as Constellation stock got crushed to new lows in the premarket on Wednesday, we formulated a couple of longer-term options ideas, and wanted to provide updates on the activity there as well.

We were banking on STZ reversing off of those lows and beginning a recovery, and so far, it’s going quite well. Our targets were the  the STZ 02/01 $150-157.50 Calls and the 04/18 $160-170 Calls, and all seven sets of contracts in those ranges have been good for significant gain opportunities. These remain in play, and will remain on our watchlist going forward.

02/01 $150-157.50 Calls
$150 Calls – Range: 8.80-11.50 – Max Gain: 31%
$152.50 Calls – Range: 3.80-6.70 – Max Gain: 76%
$155 Calls – Range: 2.90-8.00 – Max Gain: 176%
$157.50 Calls – Range: 3.00-6.65 – Max Gain: 122%

04/18 $160-170 Calls

$160 Calls – Range: 5.50-10.83 – Max Gain: 97%
$165 Calls – Range: 4.00-8.01 – Max Gain: 101%
$170 Calls – Range: 2.78-6.07 – Max Gain: 118%
_____

Fresh Ideas:
GM Weekly $36-37.50 Calls
TLRY Weekly $92.50-95 Calls  


China SXT Pharma Inc SXTC

To wrap things up we wanted to go over the call we made on Monday morning in SXTC, which at the time had registered a low of 5.684. After steadily ramping up all week, yesterday the stock reached a new high of 23.35. That worked out to an incredible four-day swing of 311%

Cheers to anyone who caught this mover in Monday morning’s premarket report. It adds to an already impressive start for us here in 2019.


Extended Watchlist:
FTK, AQMS, MGEN, NAVB, SNSS, CFRX, TEUM

Blue Horseshoe Stocks: Bottom Watchlist, Options Idea & More

Cannabis Sativa, Inc. CBDS

CBDS was part of our cannabis stock watchlist yesterday, and even as the majority of the sector was seen to be fading, CBDS bucked the trend and produced an excellent intraday opportunity.

We watched as the stock took off like a rocket right at the opening bell from a low of 1.26, and didn’t stop until hitting its 2.45 high-of-day shortly before 11′clock. That works out to a 94% swing and it came on immense volume, to the tune of 23X the 3-month average.

Cheers go out to any of our readers who caught a piece of the action on CBDS, which was the first in a trio of selections from yesterday’s premarket report to produce respectable intraday performances.


Cardinal Resources, Inc. CDNL

Next in line was CDNL, which is a stock that we’ve referenced in our reports on numerous occasions over the past several months. This subpenny runner turned in an intraday rip of 77% as it ran from .0047-.0083 on a little more than twice the average trading volume, and managed to hold the majority of its daily advance into the close at .0074.

It marked the second consecutive big day for the stock trending off of its lowest prices in roughly six months, so we’ll certainly want to continue tracking its activity, watching for it to record higher highs and higher lows in coming sessions.


Celator Pharmaceuticals, Inc. CPXX

We caught CPXX yesterday on the heels of an attention-grabbing PR (link below) which hit wires post-market on Monday afternoon, relating to encouraging results from a late-stage clinical trial. Despite already being up close to 300%, we still felt it warranted a tag in our watchlist, and we weren’t disappointed.

As is often the case in such circumstances, we saw a dip-and-rip unfold early, after which time the stock ran from a low of 6.44 to 9.10, for a solid 41% swing on absolutely massive volume.


Bottom-Watchlist

We’re going to designate the following stocks as bottom-watch plays and reserve a spot on our watchlist for each of them over the next several sessions:

Pernix Therapeutics Holdings, Inc.  PTX
Sunesis Pharmaceuticals, Inc  SNSS
Peak Resorts, Inc.  SKIS
Quantum Fuel Systems Technologies Worldwide Inc.  QTWW


Chipotle Mexican Grill, Inc. CMG -  Options Idea

We want to throw in a quick options idea this morning as well, and it’s going to come in the form of a short. Specifically, we’re going to be looking at the CMG Weekly $485-475 Puts.


Extended Watchlist:
VPRO, UPL, PSG, SIPC, LEAS, POTG

Blue Horseshoe Stocks: NUGN on Bottom-Watch & More

NuGene International, Inc. NUGN

We’re mentioning NUGN for the first time this morning on the heels of some interesting events that have recently unfolded. The stock had been on a sustained uptrend for over two months that was apparently the product of a massive promotion (in which we played no role) which resulted in the PPS running from below $2 to more than $4.

On Wednesday, the company issued a public statement to clarify that it was not involved in promotional activities of any sort >>Read PR

What followed yesterday was a massive sell-off to the tune of nearly 40%, and that’s where we enter the picture. Regardless of the catalysts behind NUGN’s gradual rise and rapid fall, we’re only interested in the chart activity that will follow. We’re going to highlight NUGN as a bottom-watch play, because the resultant bounce when the stock finds a solid level of support could make quick-strike gains a snap for those paying close enough attention.


Fresh News Plays

We’re going to tag both of the following for observation today after each published notable premarket PR’s this morning:

AmeriMex International, Inc. AMMX

In addition to announcing the latest in a long string of recently secured purchase agreements (links below), the AMMX chart is looking rather bullish at the moment.

_______

Corbus Pharmaceuticals Holdings, Inc. CRBP

We’ll also keep an eye on CRBP, which has some FDA-related news out today.

Corbus Pharmaceuticals Announces FDA Orphan Drug Designation for Resunab(TM) for the Treatment of Systemic Sclerosis (Scleroderma) (Fri 8:12AM EDT)


Options Idea:

Twitter, Inc. TWTR is responding well in the wake of the revelation that its current CEO will be stepping down on July 1st. We’re going to put TWTR Weekly $36-38 Calls on watch today as well, for potential daytrading opportunities.


Extended Watchlist:
SNSS, OCLS, ESI, OSUR